CFDB - Cystic Fibrosis DataBase

Welcome in CFDB (Cystic Fibrosis DataBase)!

This is a web-based, free access tool for health care professionals, researchers and students to evaluate in real time what are the current evidences about clinical efficacy of interventions in CF.

You'll find more than 1,500 studies divided in 8 sections, including Cochrane reviews, Cochrane protocols, DARE, HTA and Economic reviews, published RCT, published non-RCT, congress abstracts and ongoing trials.

Objective of CFDB (Cystic Fibrosis DataBase)

CFDB is a database and was ideated to classify clinical studies to get answers to specific questions:

  • which interventions are effective, in which groups of CF patients and for which outcomes?
  • to what extent do the results of the literature allow to make decisions for specific clinical issues? What issues need to be studied further?

This tool may help clinicians, researchers, students to have a faster updated view of clinical research in CF by using queries on the main topics in CF care. It could also be helpful to anyone going to design new studies, as it provides a concise description of what is currently known and what issues, on the contrast, need additional research.

Latest articles

Inhaled corticosteroids for cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2019
  • Balfour-Lynn Ian M

Singing as an adjunct therapy for children and adults with cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2019
  • Irons JY

Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.

primary studies published RCT

Details
  • 2019
  • Ratjen F

Effects of Exercise Intervention Program on Bone Mineral Accretion in Children and Adolescents with Cystic Fibrosis: A Randomized Controlled Trial.

primary studies published RCT

Details
  • 2019
  • Gupta S

A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - Phase 2 - Not yet recruiting

ongoing trials trial from www.clinicaltrials.gov

Details
  • 2019
  • Boehringer Ingelheim

Sildenafil Exercise: Role of PDE5 Inhibition - Phase 2|Phase 3 - Not yet recruiting

ongoing trials trial from www.clinicaltrials.gov

Details
  • 2019
  • National Jewish Health|Augusta University|Cystic Fibrosis Foundation

HFNT During Exercise in CF - Not Applicable - Recruiting

ongoing trials trial from www.clinicaltrials.gov

Details
  • 2019
  • The Leeds Teaching Hospitals NHS Trust